Clinical Trial Update: Assessing of Artificial Intelligence-based Software Platform for Diabetic Retinopathy Screening

View source ↗

Summary

A clinical trial is evaluating an AI-based software platform for diabetic retinopathy screening and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Snippet

Sponsor: The Filatov Institute of Eye Diseases and Tissue Therapy | Conditions: Diabetic Retinopathy | Status: RECRUITING